The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Nepafenac Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on Nepafenac (Nevanac, Ilevro) availability, supply chain status, and practical alternatives for ophthalmologists and prescribers in 2026.
Olumiant Shortage: What Providers and Prescribers Need to Know in 2026
Olumiant access barriers affect rheumatology and dermatology patients daily. Here's what providers need to know about availability, prior auth, and alternatives in 2026.
Pylera Shortage: What Providers and Prescribers Need to Know in 2026
Pylera isn't on the FDA shortage list, but your patients may still struggle to find it. Here's what's driving access issues in 2026 and how to support your patients.
Rhinocort Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on Rhinocort (budesonide nasal spray) availability in 2026: OTC vs. Rx landscape, alternatives, formulary tips, and patient support tools.
37,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Spritam Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for neurologists and prescribers on Spritam availability in 2026 — supply context, prescribing strategies, and patient support resources.
Strattera (Atomoxetine) Supply Issues: What Providers and Prescribers Need to Know in 2026
A clinical overview of the atomoxetine supply landscape in 2026 — including the 2023 brand discontinuation, 2025 Glenmark recall, and patient management strategies.
Sulfamethoxazole/Trimethoprim Shortage: What Providers and Prescribers Need to Know in 2026
A 2026 clinical guide for prescribers managing sulfamethoxazole/trimethoprim availability gaps, including therapeutic substitution and patient counseling strategies.
Topamax Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on topiramate availability in 2026 for neurologists, PCPs, and other prescribers. Covers supply status, formulary considerations, and patient guidance.
Yupelri Availability: What Providers and Prescribers Need to Know in 2026
Yupelri (revefenacin) presents unique access challenges for prescribers. Here's the 2026 clinical guidance on availability, formulary barriers, and patient support strategies.
Mesalamine XR Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on Mesalamine XR availability in 2026: ASHP shortage status, prescribing implications, alternative formulations, and patient access tools.
Dorzolamide Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview for ophthalmologists, optometrists, and prescribers on dorzolamide availability in 2026, including patient counseling tips, therapeutic alternatives, and formulary considerations.
How to Help Your Patients Save Money on Feirza 1/20: A Provider's Guide to Savings Programs
A provider's guide to helping patients reduce out-of-pocket costs for Feirza 1/20 in 2026 — ACA coverage mandates, discount programs, Medicaid, and prescribing strategies.